What is IBB's relative strength rating?

Relative strength percentiles for IBB are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.

What sector is IBB in?

IBB is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is IBB in a leading sector?

Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

IBB currently shows a 20-day average daily range (ADR%) of 1.8%, a 90-day beta versus the S&P 500 of 0.53. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does IBB have a seasonal pattern?

TickerStance computes IBB's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what IBB has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did IBB last report earnings?

No SEC EDGAR filings are linked to IBB in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

iShares Biotechnology ETF (IBB) · Neutral

Free

Dossier · Pro

iShares Biotechnology ETF · Other

$212.53▼-0.48%

Neutral · stance 47.8

Loading ticker…

§ Seasonality

10y · since 2022

Best monthNov on averageavg +5.63% · 100% win · n 4

Worst monthApr on averageavg -3.61% · 20% win · n 5

IBB monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	IBB Jan avg: 2.49% median: 3.09% win: 75% σ: 2.64% n: 4 2022-04-12 → 2026-07-31	IBB Feb avg: -1.13% median: 0.27% win: 50% σ: 4.07% n: 4 2022-04-12 → 2026-07-31	IBB Mar avg: -2.14% median: -1.72% win: 50% σ: 3.76% n: 4 2022-04-12 → 2026-07-31	IBB Apr avg: -3.61% median: -1.03% win: 20% σ: 5.07% n: 5 2022-04-12 → 2026-07-31	IBB May avg: 0.10% median: 0.02% win: 60% σ: 3.86% n: 5 2022-04-12 → 2026-07-31	IBB Jun avg: 3.66% median: 2.53% win: 100% σ: 4.04% n: 5 2022-04-12 → 2026-07-31	IBB Jul avg: 3.62% median: 4.94% win: 80% σ: 3.78% n: 5 2022-04-12 → 2026-07-31	IBB Aug avg: 0.42% median: -0.16% win: 50% σ: 2.64% n: 4 2022-04-12 → 2026-07-31 (current)	IBB Sep avg: -1.49% median: -2.72% win: 25% σ: 4.18% n: 4 2022-04-12 → 2026-07-31	IBB Oct avg: 2.41% median: 3.15% win: 50% σ: 9.06% n: 4 2022-04-12 → 2026-07-31	IBB Nov avg: 5.63% median: 6.28% win: 100% σ: 3.42% n: 4 2022-04-12 → 2026-07-31	IBB Dec avg: -0.25% median: -3.37% win: 25% σ: 8.54% n: 4 2022-04-12 → 2026-07-31

Filed: Mar 2026

HOLDINGS

Top holdings of IBB

Top 25 holdings of IBB by portfolio weight
#	Holding	Weight	Value
1	GILD	7.75%	$629M
2	AMGN	7.51%	$610M
3	VRTX	7.44%	$605M
4	REGN	7.21%	$586M
5	ALNY	3.99%	$324M
6	INSM	3.20%	$260M
7	ARGX	3.07%	$250M
8	BIIB	2.46%	$200M
9	NTRA	2.41%	$196M
10	UTHR	2.30%	$187M
11	ONC	1.93%	$157M
12	INCY	1.70%	$138M
13	MRNA	1.68%	$137M
14	ILMN	1.68%	$136M
15	RVMD	1.54%	$125M
16	Roivant Sciences Ltd.	1.24%	$101M
17	NBIX	1.18%	$96M
18	GMAB	1.17%	$95M
19	BBIO	1.13%	$92M
20	IONS	1.11%	$91M
21	MEDP	1.00%	$82M
22	MDGL	1.00%	$81M
23	EXEL	0.99%	$80M
24	BMRN	0.98%	$80M
25	Ascendis Pharma A/S	0.96%	$78M

Showing 25 of 236 holdings.

CONCENTRATION

Portfolio shape

47.4%Top 10 holdings

236Total holdings

211 (89%)Resolved tickers

SECTORS

Sector breakdown

Healthcare

88.4%

Industrials

3.5%

Technology

0.4%

Other

0.1%

Unclassified

5.5%

INTERNALS

What the holdings are doing

Above 50dma (count): 68%
Above 50dma (weight): 78.9%
Above 200dma (count): 66%
Above 200dma (weight): 81.4%

Stage mix (by weight)

Stage 1 · 14% of holdingsStage 2 · 40% of holdingsStage 3 · 24% of holdingsStage 4 · 22% of holdings

Median 1M RS: 70
Median 3M RS: 76
Median 6M RS: 68

Accumulation/distribution mix

A: 27%B: 36%C: 20%D: 15%E: 1%

Metrics matched 209 tickers across 236 holdings rows (91.9% of fund weight). Metrics as of 2026-08-24; holdings from the 2026-03-31 filing.

WHAT CHANGED

Between filings

Position changes from the 2025-09-30 to the 2026-03-31 N-PORT filing.

New positions

New positions holdings in IBB
Holding	Before → after	Δ weight
ABVXAbivax SA	— → 0.50%	—
KODKodiak Sciences, Inc.	— → 0.20%	—
CAICaris Life Sciences, Inc.	— → 0.20%	—
DFTXDefinium Therapeutics, Inc.	— → 0.16%	—
ATAIAtaiBeckley, Inc.	— → 0.09%	—

+29 more

Added

Added holdings in IBB
Holding	Before → after	Δ weight
REGNRegeneron Pharmaceuticals, Inc.

LEADERS INSIDE THE FUND

Leaders inside IBB

Holdings of IBB currently on TickerStance stock-RS leaderboards.

Holdings of IBB on stock-RS leaderboards
Ticker	Weight	Lens	Rank	Stage
NTRA	2.41%	3M RS	187	Stage 2
MRNA	1.68%	3M RS	6	Stage 2
RVMD	1.54%	1Y RS	27	Stage 2
PRAX	0.77%	1Y RS	12	Stage 2
CRL	0.77%	3M RS	86	Stage 2
ARWR	0.75%	1Y RS	55	Stage 2
HALO	0.69%	3M RS	203	Stage 2
RGEN	0.58%	3M RS	210	—
KYMR	0.53%	1Y RS	162	Stage 2

THEME EXPOSURE

Theme exposure inside IBB

Human Therapeutics — 66% of weight Obesity & Weight-Loss Therapeutics — 16% of weight

SIMILAR FUNDS BY HOLDINGS

Funds similar to IBB

FAQ

Fund FAQ

What does IBB hold?: IBB holds 236 positions; its three largest are GILD (7.75%), AMGN (7.51%), and VRTX (7.44%) as of Mar 2026.
How concentrated is IBB?: The top 10 holdings account for 47.4% of IBB's portfolio. Highly concentrated in top names.
What sectors does IBB cover?: IBB's largest sector exposures are Healthcare (88.4%), Industrials (3.5%), and Technology (0.4%).
How fresh is this data?: Holdings are sourced from SEC N-PORT-P filings, published quarterly with a ~60 day lag. The most recent filing for IBB is dated Mar 2026.

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

—

LDR

—

StageWeinstein stage analysis

Stage 2 · Uptrend✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Evidence · 3 of 3

Market backdrop

Pull-back risk if Macro turns < 60

Trend44.9Are the major indexes going up or down lately?30% weight Breadth50.6Is the rally broad-based or narrow?30% weight Leadership42.4Who's leading?20% weight Macro59.0What does the credit & rates environment say?20% weight

Stance47.8● Neutral

Public attention · IBB

Is the crowd watching?

No attention data for this ticker yet — it joins the daily scan once a baseline builds.

FAQ

Frequently asked questions

What is IBB's relative strength rating?: Relative strength percentiles for IBB are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.
What sector is IBB in?: IBB is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is IBB in a leading sector?: Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is IBB?: IBB currently shows a 20-day average daily range (ADR%) of 1.8%, a 90-day beta versus the S&P 500 of 0.53. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does IBB have a seasonal pattern?: TickerStance computes IBB's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what IBB has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Added holdings in IBB
Holding	Before → after	Δ weight
REGNRegeneron Pharmaceuticals, Inc.

iShares Biotechnology ETF (IBB) · Neutral | TickerStance

Trimmed

Trimmed holdings in IBB
Holding	Before → after	Δ weight
ALNYAlnylam Pharmaceuticals, Inc.	5.68% → 3.99%	−1.69 pp
TEMTempus AI, Inc.	0.77% → 0.43%	−0.34 pp
VRTXVertex Pharmaceuticals, Inc.	7.66% → 7.44%	−0.22 pp
GMABGenmab A/S	1.38% → 1.17%	−0.20 pp
LEGNLegend Biotech Corp.	0.41% → 0.22%	−0.19 pp

+45 more

Exited

Exited holdings in IBB
Holding	Before → after	Δ weight
IQVIQVIA Holdings, Inc.	3.18% → —	—
MTDMettler-Toledo International, Inc.	2.49% → —	—
WATWaters Corp.	1.77% → —	—
Verona Pharma plc	0.59% → —	—
Avidity Biosciences, Inc.	0.50% → —	—

+26 more

IBB is not confirmed as a leader.

§ Seasonality

Top holdings of IBB

Portfolio shape

Sector breakdown

What the holdings are doing

Between filings

Leaders inside IBB

Theme exposure inside IBB

Funds similar to IBB

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

Market backdrop

Is the crowd watching?

Frequently asked questions

How much does it move?

§ Seasonality

What the holdings are doing

Theme exposure inside IBB

Funds similar to IBB

Between filings

Leaders inside IBB

iShares Biotechnology ETF (IBB) — Stance & relative strength

iShares Biotechnology ETF (IBB) — Stance & relative strength

IBB is not confirmed as a leader.

Top holdings of IBB

Portfolio shape

Sector breakdown

What the holdings are doing

Between filings

Leaders inside IBB

Theme exposure inside IBB

Funds similar to IBB

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

Market backdrop

Is the crowd watching?

Frequently asked questions

How much does it move?

What the holdings are doing

Theme exposure inside IBB

Funds similar to IBB

Between filings

Leaders inside IBB